Ectopic Cushing’s syndrome due to thymic neuroendocrine tumours: a systematic review
Sign Up to like & getrecommendations! Published in 2021 at "Reviews in Endocrine and Metabolic Disorders"
DOI: 10.1007/s11154-021-09660-2
Abstract: Knowledge of ectopic Cushing’s syndrome (CS) due to thymic neuroendocrine tumours (NETs) comes from short series or single cases. Our aim is to perform a systematic review using PubMed, Embase, Scopus, Ovid Medline and Biosis… read more here.
Keywords: due thymic; thymic neuroendocrine; ectopic cushing; cushing syndrome ... See more keywords
Thymic Neuroendocrine Tumors and Thymic Carcinoma: Demographics, Treatment, and Survival
Sign Up to like & getrecommendations! Published in 2020 at "Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery"
DOI: 10.1177/1556984520949287
Abstract: Objective Although rare, thymic neuroendocrine tumors (TNET) and thymic carcinoma (TC) are the most common thymic nonthymomatous malignancies; their survival outcomes have not been thoroughly compared. We analyzed the clinical, treatment, and survival characteristics of… read more here.
Keywords: thymic neuroendocrine; thymic carcinoma; treatment; neuroendocrine tumors ... See more keywords
Clinical implications of immune checkpoint markers and immune infiltrates in patients with thymic neuroendocrine neoplasms
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.917743
Abstract: The potential response of immune checkpoint blockade (ICB) in thymic neuroendocrine neoplasms (T-NEN) is largely unknown and full of great expectations. The expression of immune checkpoint molecules and immune infiltrates greatly determine the response to… read more here.
Keywords: immune checkpoint; thymic neuroendocrine; checkpoint; neuroendocrine neoplasms ... See more keywords